Allworth Financial LP Leap Therapeutics, Inc. Transaction History

Allworth Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	BUY	$0.29 - $0.72 $101 - $252	350 Added 43.75%	1,150 $0
Q4 2022 Jan 13, 2023	BUY	$0.42 - $9.18 $336 - $7,344	800 New	800 $0
Q2 2021 Aug 02, 2021	SELL	$1.48 - $1.92 $3,334 - $4,325	-2,253 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$1.82 - $3.01 $2,366 - $3,912	-1,300 Reduced 36.59%	2,253 $4,000
Q4 2020 Jan 26, 2021	BUY	$1.49 - $2.37 $5,293 - $8,420	3,553 New	3,553 $8,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $272M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.